Drug Discovery World

APRIL 3, 2023

DS: What motivated you and Dr David Bunka, CTO, to create Aptamer and did you imagine you would one day be operating on such a global scale?    AT : We initially met at the University of Leeds, where David was a post-doctoral researcher studying aptamers, and I was completing my PhD.

Science 130

Science Molecular Biology Therapies Disease 130

The Pharma Data

DECEMBER 8, 2020

. “I think anyone who’s been a fan of rap music across the last two decades — myself included — had a feeling this was happening,” said study author Alex Kresovich, a doctoral fellow in the Hussman School of Journalism and Media at the University of North Carolina at Chapel Hill.

Doctors 52

Doctors Treatment Research 52

PLOS: DNA Science

OCTOBER 5, 2023

Listen to doctors, do research, then finally decide. A 2008 study exonerated the Stockholm subway from causing lung cancer in men. I took the most drastic action – I had reason to believe my case was worse than the others. The car was a hotbed of benzene but the subway car not so bad.

DNA 78

DNA Treatment Science Doctors 78

The Pharma Data

AUGUST 16, 2020

“We are very optimistic the addition of this new approved treatment option will make a meaningful difference for those living with NMOSD, those who love and support them and the doctors who treat them,” said Victoria Jackson, founder, The Guthy-Jackson Charitable Foundation. Neuroscience is a major focus of research and development at Roche.

FDA Approval 52

FDA Approval FDA Clinical Trials Treatment 52

Codon

APRIL 9, 2024

Chinese researchers scoured ancient medical texts containing written records of malaria outbreaks and the plant-derived recipes that were used to treat them nearly two thousand years ago. Over the course of 12 years, the Walter Reed Army Institute of Research (WRAIR) screened more than 250,000 compounds in search of an efficacious treatment.

Drugs 132

Drugs Science Research Doctors 132

Codon

AUGUST 27, 2024

Doctors in training are told that when they hear hoofbeats, they should think horses, not zebras; rare diseases are the exception, not the rule. While reading all the sequences present in a sample, researchers want to find any that are out of place, such as those that belong to a never-before-seen virus.

DNA 90

DNA Hospitals Laboratories Virus 90

The Pharma Data

JUNE 28, 2021

Bayer´s development partner, Janssen Research & Development, LLC has submitted a New Drug Application (NDA) to the U.S. Since launch in 2008, more than 86 million patients have been treated. Rivaroxaban was discovered by Bayer, and is being jointly developed with Janssen Research & Development, LLC.

FDA 52

FDA Clinical Trials Treatment Therapies 52

The Pharma Data

MAY 14, 2021

” Before Prasara Yoga, I had studied the science of flow with the top researchers in the former Soviet Union, where sport was a political platform. Billions of Rubles were spent in this “think-tank” of Olympic Coaches, Special Forces Trainers, Psycho-Physiologists and Biomechanics Researcher Doctors.

Packaging 52

Packaging Production Doctors International 52

The Pharma Data

MAY 15, 2021

And the doctors? I knew I needed to take my research “off-grid”, and…. …on I started doing things with my body that not only shocked the hell out of the doctors who told me my best days were behind me… but gave my “glory days” a run for their money. It contains all of my research, tests, experiments and “top secret” programming.

Production 52

Production Packaging Doctors Science 52

Drug & Device Law

OCTOBER 10, 2022

And, citing research related to cancer drugs, the manufacturer asserted that “49% of cancer patients failed to refill their prescriptions when the out-of-pocket costs exceeded $2,000.” 3 (2008), the court explained that “the word ‘includes,’ when used in a statute, ‘is usually a term of enlargement, and not of limitation.’” Pfizer, Inc. ,

Drugs 52

Drugs FDA Approval FDA Disease 52

Drug & Device Law

JUNE 28, 2022

In enacting the FDCA, Congress created the FDA and charged it with “promot[ing] the public health by promptly and efficiently reviewing clinical research and taking appropriate action on the marketing of regulated products in a timely manner.” 22, 2008)), aff’d , 919 F.3d 1, 16-22 (2016) (collecting examples). 3d 644, 678 (S.D.N.Y.

FDA Approval 116

FDA Approval FDA Regulations Drugs 116

Drug & Device Law

JUNE 6, 2022

Further, “both doctors testified that they still prescribe [the drug] for patients with conditions similar to plaintiff’s condition.” The prescriber] provided explicit, uncontroverted testimony that, even when provided with the most current research and FDA mandated warnings, as well as the information found in [defendant’s] updated. . .

Testimonials 59

Testimonials Production Pharmaceuticals Treatment 59

Drug & Device Law

FEBRUARY 21, 2022

11, 2022), granted a Rule 702 motion excluding plaintiff’s purported FDA expert Peggy Pence, who “began working as an expert witness for plaintiffs in product liability cases in 2008” and “approximately 100% of her work was as a plaintiff’s expert in product liability litigation.” The court should view that opinion with skepticism. . . .

Testimonials 59

Testimonials Clinical Trials Production Trials 59

Drug & Device Law

DECEMBER 11, 2023

Defendant] does not deny that it, the doctor, and the hospital are potential joint tortfeasors. . . . GlaxoSmithKline , 2008 WL 11515533, at *3 n.10 June 5, 2008) (all finding medical malpractice defendants dispensable in prescription product liability litigation litigation in non-removal situations). Synthes Corp. ,

Production 102

Production Hospitals Pharmaceuticals Doctors 102